Log In
Print this Print this

pyronaridine/artesunate (Pyramax)

  Manage Alerts
Collapse Summary General Information
Company Shin Poong Pharmaceutical Co. Ltd.
DescriptionFixed-dose oral combination of 180 mg pyronaridine and 60 mg artesunate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today